SCHEMBL30121790

SCHEMBL30121790

Nc1nc(Nc2ccc(CN3CCC(N4CCCC4)CC3)cc2)n(-c2cc3c(nn2)-c2ccccc2CCC3)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 8/20 0.59
AURKA O14965 1/20 0.59
EGFR P00533 1/20 0.59
RET P07949 1/20 0.59
MET P08581 1/20 0.59
KIT P10721 1/20 0.59
SRC P12931 1/20 0.59
PDGFRA P16234 1/20 0.59
KDR P35968 1/20 0.59
FLT3 P36888 1/20 0.59
TYRO3 Q06418 1/20 0.59
DDR1 Q08345 1/20 0.59
MERTK Q12866 1/20 0.59
AURKB Q96GD4 1/20 0.59
ALK Q9UM73 1/20 0.59
ACHE P22303 6/20 0.46
BCHE P06276 5/20 0.46
CHRM4 P08173 1/20 0.46
USP2 O75604 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL467846 1.00 AXL (0.59) AXLAURKAEGFRRETMET
SCHEMBL1640367 0.95 AXL (0.56) AXLAURKAEGFRRETMET
SCHEMBL468644 0.88 AXL (0.61) AXLAURKAEGFRRETMET
SCHEMBL1639457 0.88 AXL (0.77) AXLAURKAEGFRRETMET
SCHEMBL30121612 0.87 AXL (0.77) AXLAURKAEGFRRETMET
SCHEMBL467825 0.87 AXL (0.77) AXLAURKAEGFRRETMET
SCHEMBL467824 0.87 AXL (0.77) AXLAURKAEGFRRETMET
SCHEMBL1640337 0.87 AXL (0.46) AXLAURKAEGFRRETMET
SCHEMBL467730 0.86 AXL (0.75) AXLAURKAEGFRRETMET
SCHEMBL467608 0.85 AXL (0.74) AXLAURKAEGFRRETMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4138823-A1 METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR BerGenBio ASA (NO) 2023-03-01 EP disclosed
EP-4125908-A1 COMBINATION THERAPY COMPRISING AN AXL INHIBITOR BerGenBio ASA (NO) 2023-02-08 EP disclosed